Lupin 2024

May 29, 2023

You can read the full May 29 print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!

Fauci: COVID revealed Rx’s vital role in health care

Fauci: COVID revealed Rx’s vital role in health care

PALM BEACH, Fla. — Anyone who has lingering doubts about the centrality of retail pharmacy’s contribution to ending the COVID pandemic should consider the view of Dr. Anthony Fauci, the federal government’s point man in responding to the emergency. Speaking at the National Association of Chain Drug Stores’ Annual Meeting here last month, the former

Tech’s challenge to health care industry mounting

Tech’s challenge to health care industry mounting

Consumers today expect high-quality experiences, not just deals, and health care is no exception. In fact, consumers are demanding more from the third-largest industry in the United States by GDP. Yet as tech companies find new ways to enter the market, health care incumbents continue to fall behind. In January, Amazon launched RxPass, an inexpensive

Miracle Headache Relief’s cool compression targets pain

Miracle Headache Relief’s cool compression targets pain

FAIRFIELD, N.J. — Over the years the headache pain category has seen a wide variety of solutions for consumers. One unique product hitting store shelves this spring is Miracle Headache Relief from Ontel Products Corp. Craig Jordan, senior vice president of sales and customer solutions, says it is “the ultra-soothing, cold gel compression wrap that

Drug makers and chains need a supply chain revamp

Drug makers and chains need a supply chain revamp

Does your supply chain keep you up at night? Due to ongoing market disruption, companies’ risk exposure has never been greater. Now is the time to design supply chains that can overcome risk today and thrive in the future. COVID-19 illustrated the vulnerability of supply chains to significant demand shifts and supply shocks caused by

Plan B label change corrects misconceptions

Plan B label change corrects misconceptions

NEW YORK — The Food and Drug Administration-approved label change clarifying Plan B One-Step’s mechanism of action was welcome news for the product and the emergency contraception category, says Tara Evans, marketing director for manufacturer Foundation Consumer Healthcare (FCH). “FCH firmly believes that access to emergency contraception is critically important, and we continue to uphold

PP_1170x120_10-25-21